EP1242443A4 - Neue nukleinsäuren und polypeptide - Google Patents

Neue nukleinsäuren und polypeptide

Info

Publication number
EP1242443A4
EP1242443A4 EP00990231A EP00990231A EP1242443A4 EP 1242443 A4 EP1242443 A4 EP 1242443A4 EP 00990231 A EP00990231 A EP 00990231A EP 00990231 A EP00990231 A EP 00990231A EP 1242443 A4 EP1242443 A4 EP 1242443A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00990231A
Other languages
English (en)
French (fr)
Other versions
EP1242443A1 (de
Inventor
Y Tom Tang
Chenghua Liu
Vinod Asundi
Rui-Hong Chen
Yunqing Ma
Xiaohong B Qian
Feiyan Ren
Dunrui Wang
Jian-Rui Wang
Zhiwei Wang
Tom Wehrman
Chongjun Xu
Aidong J Xue
Yonghong Yang
Jie Zhang
Qing A Zhao
Ping Zhou
Ryle Goodrich
Radoje T Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/620,312 external-priority patent/US6569662B1/en
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1242443A1 publication Critical patent/EP1242443A1/de
Publication of EP1242443A4 publication Critical patent/EP1242443A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP00990231A 1999-12-23 2000-12-26 Neue nukleinsäuren und polypeptide Withdrawn EP1242443A4 (de)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US662191 1991-02-28
US47127599A 1999-12-23 1999-12-23
US471275 1999-12-23
US48872500A 2000-01-21 2000-01-21
US488725 2000-01-21
US55231700A 2000-04-25 2000-04-25
US552317 2000-04-25
US59804200A 2000-06-20 2000-06-20
US598042 2000-06-20
US09/620,312 US6569662B1 (en) 2000-01-21 2000-07-19 Nucleic acids and polypeptides
US620312 2000-07-19
US65345000A 2000-08-31 2000-08-31
US653450 2000-08-31
US66219100A 2000-09-14 2000-09-14
US69303600A 2000-10-19 2000-10-19
US693036 2000-10-19
US72734400A 2000-11-29 2000-11-29
WOPCT/US72/07344 2000-11-29
PCT/US2000/034263 WO2001053312A1 (en) 1999-12-23 2000-12-26 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
EP1242443A1 EP1242443A1 (de) 2002-09-25
EP1242443A4 true EP1242443A4 (de) 2005-06-22

Family

ID=27578844

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00990231A Withdrawn EP1242443A4 (de) 1999-12-23 2000-12-26 Neue nukleinsäuren und polypeptide

Country Status (3)

Country Link
EP (1) EP1242443A4 (de)
CA (1) CA2402563A1 (de)
WO (1) WO2001053312A1 (de)

Families Citing this family (198)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2002502589A (ja) 1998-02-09 2002-01-29 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ４５個のヒト分泌タンパク質
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6369197B1 (en) 1998-11-20 2002-04-09 Millennium Pharmaceuticals, Inc. Potassium channel interactors and uses therefor
US7078481B1 (en) 1998-11-20 2006-07-18 Wyeth Potassium channel interactors and uses therefor
ES2321954T3 (es) * 1999-03-08 2009-06-15 Genentech, Inc. Composiciones y procedimientos para el diagnostico de tumores.
US7232889B2 (en) 1999-03-08 2007-06-19 Genentech, Inc. PRO300 antibodies
US8410248B2 (en) 1999-03-12 2013-04-02 Human Genome Sciences Inc. HWBAO62 polypeptides
US7083791B2 (en) 1999-03-25 2006-08-01 Genesis Research & Development Corporation Limited Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
US6242419B1 (en) * 1999-03-25 2001-06-05 Genesis Research & Development Corporation Ltd. Compositions isolated from stromal cells and methods for their use
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2374612A1 (en) 1999-05-28 2000-12-07 Immunex Corporation Novel murine and human kinases
EP1637541B1 (de) * 1999-09-01 2010-03-03 Genentech, Inc. Ausgeschiedene Polypeptide und Transmembranpolypeptide und dafür kodierende Nukleinsäuren
EP1661997A1 (de) * 1999-12-01 2006-05-31 Genentech, Inc. Ausgeschiedene und Transmembranpolypeptide und dafür kodierende Nukleinsäuren
US7423127B2 (en) * 1999-12-09 2008-09-09 Genentech, Inc. Antibodies to a polypeptide encoded by a nucleic acid overexpressed in melanoma
US20090176722A9 (en) 2000-01-28 2009-07-09 Shiv Srivastava Androgen-regulated PMEPA1 gene and polypeptides
EP1263939B1 (de) * 2000-02-11 2009-07-01 Millennium Pharmaceuticals, Inc. 18477, eine menschliche proteinkinase und deren verwendung
US6479270B1 (en) * 2000-02-14 2002-11-12 Pe Corporation (Ny) Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
AU2001235696A1 (en) * 2000-02-17 2001-08-27 Aventis Pharma S.A. Compositions useful for regulating parkin gene activity
CA2401173A1 (en) * 2000-03-02 2001-09-07 Curagen Corporation G12l, a gene associated with the thermal response
US20020111307A1 (en) * 2000-06-23 2002-08-15 Glucksmann Maria Alexandra 46508, a novel human peptidyl-tRNA hydrolase family member and uses thereof
US20040214758A1 (en) 2000-03-24 2004-10-28 Meyers Rachel E. Novel human hydrolase family members and uses thereof
US20020065223A1 (en) * 2000-06-16 2002-05-30 Glucksmann Maria Alexandra 33358, a novel human ankyrin family member and uses thereof
GB0018307D0 (en) 2000-07-26 2000-09-13 Aventis Pharm Prod Inc Polypeptides
IL151987A0 (en) * 2000-03-31 2003-04-10 Aventis Pharma Inc Nuclear factor kb inducing factor
AU2001253123A1 (en) * 2000-04-12 2001-10-30 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Identification of a renal nadph oxidase
AU5542101A (en) * 2000-04-14 2001-10-30 Univ Vanderbilt Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
US20030083244A1 (en) * 2000-04-26 2003-05-01 Vernet Corine A.M. Novel proteins and nucleic acids encoding same
EP1285060A2 (de) 2000-04-26 2003-02-26 Millennium Pharmaceuticals, Inc. 26335, eine neue humane serin-/threonin-dehydratase und ihre anwendung
US6461846B2 (en) * 2000-05-30 2002-10-08 Pe Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
DE10027170A1 (de) * 2000-05-31 2001-12-13 Schering Ag Humanes PEM als Target für die Fertilitätskontrolle
ATE385504T1 (de) 2000-06-06 2008-02-15 Bristol Myers Squibb Co Nukleinsäuren und polypeptide, die sich auf b7 beziehen und ihre verwendungen zur immunmodulierung
FR2810673B1 (fr) * 2000-06-26 2004-10-08 Univ Toulouse Dynamine mitochondriale humaine msp1 et son utilisation en therapeutique
US6900303B2 (en) 2000-06-30 2005-05-31 Millennium Pharmaceuticals, Inc. 57658, a novel human uridine kinase and uses thereof
AU2002222937A1 (en) * 2000-07-18 2002-01-30 Millennium Pharmaceuticals, Inc. 14087, a serine protease molecule and uses therefor
WO2002008282A2 (en) * 2000-07-26 2002-01-31 Stanford University Bstp-ras/rerg protein and related reagents and methods of use thereof
EP1307553A2 (de) * 2000-08-01 2003-05-07 Oregon Health & Science University Gen kodierend für ein dna-bindendes membran-assoziiertes protein aus säugern und verwendungen
AU2001283062A1 (en) 2000-08-02 2002-02-13 The Johns Hopkins University Endothelial cell expression patterns
CA2417676A1 (en) * 2000-08-03 2002-02-14 Incyte Genomics, Inc. Sequences for integrin alpha-8
ATE332309T1 (de) * 2000-08-04 2006-07-15 Ludwig Inst Cancer Res Suppressor-gen
AU8846601A (en) * 2000-08-28 2002-03-13 Agensys Inc Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
WO2002018566A2 (en) * 2000-08-31 2002-03-07 Bayer Aktiengesellschaft Regulation of human l-asparaginase-like enzyme
CA2417136A1 (en) 2000-09-01 2002-03-07 The Governing Council Of The University Of Toronto Proteins related to schizophrenia and uses thereof
CA2421122A1 (en) * 2000-09-01 2002-03-07 Hyseq, Inc. Novel nucleic acids and polypeptides
AU2001291135A1 (en) * 2000-09-19 2002-04-02 Millennium Pharmaceuticals, Inc. 63760, a novel human transporter and uses thereof
AU2001293830A1 (en) * 2000-09-27 2002-04-08 Bayer Aktiengesellschaft Regulation of human aminotransferase-like enzyme
CN1498271A (zh) * 2000-09-27 2004-05-19 ǧ��ҩƷ��˾ 钾通道相互作用蛋白及其用途
WO2002026957A2 (en) * 2000-09-28 2002-04-04 Bayer Aktiengesellschaft Regulation of a human serine protease
GB0024086D0 (en) * 2000-10-02 2000-11-15 Inpharmatica Ltd Proteinase
US6911336B2 (en) 2000-10-18 2005-06-28 Immunex Corporation GNK interacting amino acid decarboxylase and methods of use thereof
AUPR107800A0 (en) * 2000-10-27 2000-11-23 University Of Sydney, The Peptide and nucleic acid molecule ii
AUPR121300A0 (en) * 2000-11-03 2000-11-30 Monash University Cell division autoantigen (CDA) polypeptides, gene sequences and uses thereof
JP2004528822A (ja) * 2000-11-07 2004-09-24 ボード・オブ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム 筋特異的筋節カルシニューリン結合タンパク質（カルサルシン）に関する方法および組成物
JP2004537981A (ja) 2000-11-16 2004-12-24 エモリー・ユニバーシティ マイトジェンオキシゲナーゼ調節因子
AU2002224853A1 (en) * 2000-11-17 2002-05-27 Bayer Aktiengesellschaft A human trna-specific adenosine deaminase
EP1209229A1 (de) * 2000-11-21 2002-05-29 Klaus-Peter Department of Psychiatry and Psychotherapy University of Würzburg Lesch Gen, das in der Schizophrenie beteiligt ist
AU2002239229A1 (en) 2000-12-05 2002-06-18 Wisconsin Alumni Research Foundation Receptor for b. anthracis toxin
US20040072997A1 (en) * 2000-12-20 2004-04-15 Alsobrook John P. Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20040161746A1 (en) * 2000-12-21 2004-08-19 Yoshiko Matsumoto Method of testing allergic disease
AU2002249876A1 (en) * 2000-12-22 2002-08-19 Millennium Pharmaceuticals, Inc. 25828, a novel human aminopeptidase and uses therefor
WO2002053716A2 (en) * 2001-01-03 2002-07-11 Bayer Aktiengesellschaft Regulation of human ornithine decarboxylase
AUPR278301A0 (en) * 2001-01-31 2001-02-22 Bionomics Limited A novel gene
WO2002057444A1 (fr) * 2001-01-22 2002-07-25 Shinae Kondoh Genes associes a l'apoptose humaine et proteines produites associees a l'apoptose humaine
WO2002076174A2 (en) * 2001-01-22 2002-10-03 Millennium Pharmaceuticals, Inc. Fbh58295fl, a novel human amino acid transporter and uses thereof
US6686176B2 (en) * 2001-01-23 2004-02-03 Applera Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
US7601825B2 (en) 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
WO2002072830A2 (en) * 2001-02-09 2002-09-19 Incyte Genomics, Inc. Proteins associated with cell growth, differentiation, and death
WO2002064777A2 (de) * 2001-02-14 2002-08-22 Axaron Bioscience Ag Protein 7b6 und 11b4 und zugrundeliegende dna-sequenzen
WO2002064786A1 (fr) * 2001-02-15 2002-08-22 Mochida Pharmaceutical Co., Ltd. Nouveau gene tcif
US6461843B1 (en) 2001-02-16 2002-10-08 Applera Corporation Isolated nucleic acid molecules encoding human enzyme proteins, and uses thereof
EP1575984A4 (de) 2001-02-16 2006-09-06 Bristol Myers Squibb Co "identifizierung und klonierung eines neuen humanen gens, ret 16, das an der intrazellul ren signalkaskade beteiligt ist"
GB0104440D0 (en) * 2001-02-22 2001-04-11 Oxford Biomedica Ltd Novel genes
US6924358B2 (en) 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
CA2440272A1 (en) * 2001-03-16 2002-09-26 Incyte Genomics, Inc. Nucleic acid-associated proteins
US8231878B2 (en) 2001-03-20 2012-07-31 Cosmo Research & Development S.P.A. Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
US8981061B2 (en) 2001-03-20 2015-03-17 Novo Nordisk A/S Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
US20020173639A1 (en) * 2001-03-26 2002-11-21 Friddle Carl Johan Novel human asparaginases and polynucleotides encoding the same
US6867019B2 (en) * 2001-03-27 2005-03-15 Applera Corporation Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
CA2442134A1 (en) 2001-03-29 2002-10-10 Celltech R & D, Inc. Compositions and methods for diagnosing or treating psoriasis
US20030044813A1 (en) * 2001-03-30 2003-03-06 Old Lloyd J. Cancer-testis antigens
FR2823221B1 (fr) 2001-04-06 2004-04-02 Univ Pasteur Sequences associees a la degenerescence retinienne et applications
AU2002308139A1 (en) * 2001-04-12 2002-10-28 Bayer Aktiengesellschaft Regulation of human methionine aminopeptidase-like protein
EP1258495A1 (de) * 2001-05-09 2002-11-20 Millennium Pharmaceuticals, Inc. 98359, Natriumkanal-beta-4 Untereinheit, und deren Verwendungen
US7335755B2 (en) * 2001-05-30 2008-02-26 Hisamitsu Pharmaceutical Co., Inc. Nucleic acids isolated in neuroblastoma
WO2003004608A2 (en) * 2001-07-06 2003-01-16 Incyte Genomics, Inc. Drug metabolizing enzymes
WO2003006641A2 (en) * 2001-07-09 2003-01-23 Københavns Universitet Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer
CA2453653A1 (en) * 2001-07-26 2003-02-06 Genset S.A. Gmg-2 polynucleotides and polypeptides and uses thereof
US7413870B2 (en) * 2001-08-01 2008-08-19 Rigel Pharmaceuticals, Incorporated SAK: modulation of cellular proliferation for treatment of cancer
FR2828209A1 (fr) * 2001-08-01 2003-02-07 Cytomics Systems Acides nucleiques codant de nouvelles proteines a domaine hect, leurs utilisations en diagnostics et en therapie
US20030104385A1 (en) * 2001-08-02 2003-06-05 Evans Glen A. Nucleic acids and encoded polypeptides associated with bipolar disorder
JP4102898B2 (ja) * 2001-08-23 2008-06-18 独立行政法人科学技術振興機構 造血幹細胞増殖調節因子及びそれをコードするポリヌクレオチド
JP2003135063A (ja) * 2001-08-24 2003-05-13 Chiba Prefecture 新規な遺伝子ｎｅｄｌ−１
JP4625633B2 (ja) * 2001-08-27 2011-02-02 独立行政法人科学技術振興機構 細胞移動調節及び細胞死調節機能を有するタンパク質
JP2005506838A (ja) * 2001-08-31 2005-03-10 ミレニアム・ファーマシューティカルズ・インコーポレイテッド ヒトスルファターゼファミリーメンバーｍｉｄ９００２およびその使用
NZ573740A (en) * 2001-09-18 2010-07-30 Genentech Inc Compositions and methods for the diagnosis and treatment of tumor, particularly kidney tumor - TAT184
AU2008201995A1 (en) * 2001-09-18 2008-05-29 Genentech, Inc. Compositions and methods for the diagnosis and treament of tumor
JP4232423B2 (ja) * 2001-09-28 2009-03-04 第一三共株式会社 新規ユビキチン特異プロテアーゼ
WO2003029426A2 (en) * 2001-10-03 2003-04-10 Immunex Corporation Human and murine cytokine polypeptides
WO2003038093A2 (en) * 2001-10-30 2003-05-08 Bayer Healthcare Ag Regulation of human l-serine dehydratase
WO2003038113A2 (en) * 2001-10-31 2003-05-08 Millennium Pharmaceuticals, Inc. Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
US20030153525A1 (en) * 2001-12-19 2003-08-14 Millennium Pharmaceuticals, Inc. Methods and compositions in treating pain and painful disorders using 1465, 1587, 2146, 2207, 32838, 336 and 52908
US7166713B2 (en) * 2001-12-11 2007-01-23 Texas Techn University Variant cleavage stimulation factor and its encoding nucleic acid
AU2003202552A1 (en) * 2002-01-10 2003-07-24 Bayer Aktiengesellschaft Regulation of human fatty acid coa ligase-like amp-binding enzyme
WO2003060129A1 (en) * 2002-01-16 2003-07-24 Bayer Healthcare Ag Regulation of human fatty acid coa ligase-like amp-binding enzyme
AU2003210158A1 (en) * 2002-01-16 2003-07-30 Bayer Aktiengesellschaft Regulation of human fatty acid coa ligase-like amp-binding enzyme
AU2003205174A1 (en) * 2002-01-17 2003-09-02 Incyte Genomics, Inc. Molecules for disease detection and treatment
WO2003072773A1 (fr) * 2002-02-08 2003-09-04 Seikagaku Corporation Proteine fusionnee ayant une activite de glucuronyltransferase
JP2003250550A (ja) * 2002-02-25 2003-09-09 Nissui Pharm Co Ltd 脂肪細胞分化関連遺伝子およびタンパク質
GB0206684D0 (en) * 2002-03-21 2002-05-01 Babraham Inst Novel proteins
US7193069B2 (en) 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
WO2003080825A2 (en) * 2002-03-27 2003-10-02 Bayer Healthcare Ag Further bmp-2 inducible kinases and the uses thereof
CA2480635A1 (en) * 2002-03-28 2003-10-09 Allen D. Delaney Cancer associated protein kinases and their uses
CA2480386A1 (en) * 2002-03-29 2003-10-09 National Institute Of Advanced Industrial Science And Technology Novel galactose transferases, peptides thereof and nucleic acid encoding the same
WO2003082342A1 (fr) * 2002-04-01 2003-10-09 National Institute Of Advanced Industrial Science And Technology Utilisation du gene k1aa0172 pour le traitement et le diagnostic de maladies et decouverte de medicaments
AU2003230874A1 (en) * 2002-04-16 2003-11-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
AU2003233124A1 (en) * 2002-04-29 2003-11-17 Clinigenetics Assays for identifying cholesterol - lowering molecules
US7009038B2 (en) 2002-05-02 2006-03-07 Univ. Of Medicine & Dentistry Of N.J. pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof
EP2269628A3 (de) 2002-05-29 2011-04-20 DeveloGen Aktiengesellschaft Pankreas spezifische proteine
NZ536963A (en) 2002-06-07 2008-04-30 Trillium Therapeutics Inc Use of the discovery that Fc gamma receptor IIA transgenic animals are susceptible to autoimmune disease, to suppress aberrant immune activity and to treat or prevent autoimmune disease
MXPA04012560A (es) * 2002-06-13 2005-10-19 Wyeth Corp Inhibidores de la actividad genica inflamatoria y biosintesis de colesterol.
GB0214543D0 (en) * 2002-06-24 2002-08-07 Ares Trading Sa Proteins
EP1552845A4 (de) * 2002-06-26 2006-06-07 Takeda Pharmaceutical Mittel zur prävention/behandlung von krebs
WO2004007711A1 (ja) * 2002-07-10 2004-01-22 Takeda Pharmaceutical Company Limited 新規蛋白質およびその用途
JP2004097199A (ja) * 2002-07-15 2004-04-02 Keio Gijuku 腫瘍抗原のスクリーニング方法
WO2004009622A2 (en) * 2002-07-19 2004-01-29 Cellzome Ag Protein complexes of cellular networks underlying the development of cancer and other diseases
AU2003254081A1 (en) * 2002-07-24 2004-02-09 New York University Truncated rgr in t cell malignancy
AU2003251656A1 (en) * 2002-07-30 2004-02-23 Bayer Healthcare Ag Regulation of human methyltransferase
GB0217631D0 (en) * 2002-07-30 2002-09-11 Inpharmatica Ltd Proteins
WO2004020620A1 (en) * 2002-08-13 2004-03-11 Bayer Healthcare Ag Regulation of human esterase
US20070269800A9 (en) * 2002-08-28 2007-11-22 Heinz Von Der Kammer Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases
EP1396544A1 (de) * 2002-09-06 2004-03-10 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Nukleinsäuren, die für menschliche Thyroiddehydrogenasen kodieren
JP2006504413A (ja) * 2002-09-12 2006-02-09 ファーメクサ エイ／エス 自家グレリンに対する免疫化
EP1556484A2 (de) * 2002-09-13 2005-07-27 Ingenium Pharmaceuticals AG Gene für die cytoplasmische dynein-schwerkette 1, expressionsprodukte, nichthumanes tiermodell: verwendung bei neurologischen erkrankungen des menschens
AU2003266605A1 (en) * 2002-09-27 2004-04-19 Takeda Pharmaceutical Company Limited Preventives/remedies for neurodegenerative disease
US7560537B2 (en) * 2002-09-30 2009-07-14 Ludwig Institute For Cancer Research Human sarcoma-associated antigens
US7662917B2 (en) 2002-09-30 2010-02-16 Ludwig Institute For Cancer Research Human sarcoma-associated antigens
AU2003280641A1 (en) * 2002-10-30 2004-05-25 Takeda Pharmaceutical Company Limited Novel protein and dna thereof
WO2004039980A1 (en) * 2002-10-30 2004-05-13 Cancer Research Technology Limited Agents modulating mal activity
JP2006516388A (ja) * 2002-11-21 2006-07-06 ワイス ループス腎炎の治療用組成物および方法
GB0228337D0 (en) * 2002-12-05 2003-01-08 Yorkshire Cancer Res Campaign Replication protein
EP1577390B9 (de) * 2002-12-24 2011-03-30 Peking University Menschliche Gene in Verbindung mit Krebs, davon kodierte Produkte und Anwendungen davon
US20050015821A1 (en) * 2003-02-21 2005-01-20 Phenomix Corporation Sensin polypeptides, encoding nucleic acids, mutations, and methods of their identification and use
US20060148692A1 (en) * 2003-03-10 2006-07-06 Takashi Horiguchi Novel protein and its dna
AU2003901511A0 (en) * 2003-03-28 2003-04-17 Bionomics Limited Nucleic acid molecules associated with angiogenesis II
EP1464651A1 (de) * 2003-04-03 2004-10-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Dystrophin-verwandte Protein (Drop1) als Marker für Krebs
WO2004098539A2 (en) * 2003-04-30 2004-11-18 Incyte Corporation Kinases and phosphatases
CN1244595C (zh) * 2003-05-14 2006-03-08 中国科学院上海生命科学研究院 一种肿瘤抑制蛋白及其应用
WO2005017155A1 (ja) * 2003-06-18 2005-02-24 Chugai Seiyaku Kabushiki Kaisha フコーストランスポーター
FR2843753A1 (fr) * 2003-06-20 2004-02-27 Gene Signal Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
WO2004113532A1 (ja) * 2003-06-21 2004-12-29 Shigeki Higashiyama 細胞増殖抑制剤スクリーニング用タンパク質及び細胞増殖抑制剤のスクリーニング方法並びに細胞増殖抑制剤
US20060205031A1 (en) * 2003-07-07 2006-09-14 1) Universiteit Utrecht Holding B.V. Newly identified cholinephosphotransferases and ethanolaminephosphotransferases
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
EP1699478A2 (de) * 2003-09-23 2006-09-13 Meyer Pharmaceuticals, LLC Behandlung von entzündung mit einem biologischen mittel, das zur freisetzung von zytokin-rezeptoren aus zellen führt
JP2005168338A (ja) * 2003-12-09 2005-06-30 Japan Science & Technology Agency 新規タンパク質カルフォグリン、これをコードする遺伝子、薬剤、及び標的物質
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
JP4757194B2 (ja) * 2004-03-19 2011-08-24 ジェノミディア株式会社 血管内皮増殖抑制遺伝子
GB0407587D0 (en) * 2004-04-02 2004-05-05 Univ Nottingham Trent Cancer associated antigens
WO2006033460A1 (en) * 2004-09-24 2006-03-30 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers by trna-dihydrouridine synthase activity of urlc8
CN101068936A (zh) * 2004-11-22 2007-11-07 惠氏公司 用于实体瘤预后及治疗的方法和系统
GB0426146D0 (en) 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
DE102004059781A1 (de) * 2004-12-10 2006-06-22 Sanofi-Aventis Deutschland Gmbh Verwendung der Serum-/Glucocorticoid regulierten Kinase
CN101175862A (zh) * 2005-02-10 2008-05-07 肿瘤疗法科学股份有限公司 诊断膀胱癌的方法
EP1734118A1 (de) * 2005-06-15 2006-12-20 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Genom-weites RNAi-Screening zur Identifizierung von Genen die das JAK/STAT Pathway modulieren
WO2007028631A1 (en) * 2005-09-09 2007-03-15 H. Lundbeck A/S Genetic risk factor for neurodevelopmental disorders and their complications
US20070071755A1 (en) * 2005-09-27 2007-03-29 David Balasundaram Novel nucleolar GTPases and method for controlling proliferation of cells
US20090305255A1 (en) * 2006-02-01 2009-12-10 Hiroshima University Substrate Protein for M-Phase Kinase and use Thereof
EP1815863A1 (de) * 2006-02-03 2007-08-08 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Verwendung von TLR3-Agonisten zur Behandlung von neurodegenerativen Krankheiten
US7884078B2 (en) 2006-02-10 2011-02-08 Massachusetts Institute Of Technology CPG15 compounds as insulin receptor and insulin-like growth factor receptor agonists
US8933209B2 (en) 2006-04-26 2015-01-13 Abbvie Inc. Dep2 and its uses in major depressive disorder and other related disorders
WO2008106640A1 (en) 2007-03-01 2008-09-04 Cedars-Sinai Medical Center Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof
US8664359B2 (en) * 2007-06-03 2014-03-04 Oncotx, Inc. Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
EP2027889A1 (de) * 2007-06-05 2009-02-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Neuer neuronaler Lebensfähigkeitsfaktor und seine Verwendung
US9028874B2 (en) 2008-01-03 2015-05-12 Cedars-Sinai Medical Center Antioxidant nanosphere comprising [1,2]-dithiolane moieties
KR20100124326A (ko) 2008-03-14 2010-11-26 엑사젠 다이어그노스틱스, 인코포레이티드 염증성 장 질병 및 과민성 장 증후군에 대한 생체마커
EP2300451A1 (de) 2008-06-02 2011-03-30 Cedars-Sinai Medical Center Prodrugs nichtsteroider entzündungshemmender mittel mit einer grösse im nanometerbereich
KR101493125B1 (ko) 2008-11-24 2015-02-12 세다르스-신나이 메디칼 센터 항산화성 캠토테신 유도체 및 이들의 항산화성 항종양성 나노구체
WO2010094499A1 (en) 2009-02-20 2010-08-26 Ganymed Pharmaceuticals Ag Methods and compositions for diagnosis and treatment of cancer
CN102741289B (zh) 2009-11-11 2016-08-03 加尼梅德药物公司 密蛋白6(cldn6)特异性的抗体
EP2404936A1 (de) 2010-07-06 2012-01-11 Ganymed Pharmaceuticals AG Krebstherapie mittels CLDN6-zielgerichteter Antikörper im lebenden Organismus
PL3026064T3 (pl) 2011-05-13 2019-05-31 Ganymed Pharmaceuticals Gmbh Przeciwciała do leczenia nowotworu z ekspresją klaudyny 6
KR101949186B1 (ko) * 2011-05-19 2019-02-18 도레이 카부시키가이샤 면역 유도제
WO2013104798A1 (en) * 2012-01-12 2013-07-18 Cemm - Center For Molecular Medicine Of The Austrian Academy Of Sciences Modulators of immune responses
EP3196214B1 (de) 2012-02-15 2019-07-31 Novo Nordisk A/S Antikörper, die den auslösenden rezeptor binden und blockieren, der auf myeloid-zellen-1 (trem-1) exprimiert ist
RS57827B1 (sr) 2012-02-15 2018-12-31 Novo Nordisk As Antitela koja vezuju protein 1 prepoznavanja peptidoglikana
US9550830B2 (en) 2012-02-15 2017-01-24 Novo Nordisk A/S Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
US20130288980A1 (en) * 2012-04-02 2013-10-31 Buck Institute For Research On Aging Targeting senescent and cancer cells for selective killing by interference with foxo4
WO2015014376A1 (en) 2013-07-31 2015-02-05 Biontech Ag Diagnosis and therapy of cancer involving cancer stem cells
LT3172232T (lt) 2014-07-17 2024-02-12 Novo Nordisk A/S Į vietą nukreipta trem-1 antikūnų mutagenezė, skirta klampumui sumažinti
EP2977758A1 (de) 2014-07-24 2016-01-27 Université De Nice Sophia Antipolis Verfahren und Kits zur Überwachung membranöser Nephropathie
JP6615895B2 (ja) 2014-12-19 2019-12-04 エフ．ホフマン−ラ ロシュ アーゲー トランスグルタミナーゼ基質の同定およびそれに関する使用
WO2016100735A1 (en) 2014-12-19 2016-06-23 Roche Nimblegen, Inc. Microbial transglutaminases, substrates therefor and methods for the use thereof
US11054425B2 (en) 2014-12-19 2021-07-06 Roche Sequencing Solutions, Inc. System and method for identification and characterization of transglutaminase species
GB201509134D0 (en) * 2015-05-28 2015-07-15 Electrophoretics Ltd Biomolecules involved in Alzheimer's disease
PE20181897A1 (es) 2016-04-21 2018-12-11 Immatics Biotechnologies Gmbh Inmunoterapia contra el melanoma y otros tipos de cancer
MX2018012758A (es) 2016-04-21 2019-01-31 Immatics Biotechnologies Gmbh Inmunoterapia contra el melanoma y otros tipos de cancer.
JP2021519594A (ja) 2018-04-02 2021-08-12 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 抗ｔｒｅｍ−１抗体およびその使用
GB201807831D0 (en) * 2018-05-15 2018-06-27 Univ College Cardiff Consultants Ltd Cancer Vaccine
US20230104519A1 (en) * 2020-02-27 2023-04-06 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Cobra1/nelf-b as a booster for efficacy of cd8+ t cell-based therapy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046281A2 (en) * 1998-03-10 1999-09-16 Genentech, Inc. Novel polypeptides and nucleic acids encoding the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175095A (en) * 1989-07-19 1992-12-29 Calgene, Inc. Ovary-tissue transcriptional factors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046281A2 (en) * 1998-03-10 1999-09-16 Genentech, Inc. Novel polypeptides and nucleic acids encoding the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JACOBS K A ET AL: "A genetic selection for isolating cDNAs encoding secreted proteins", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 198, no. 1-2, 1 October 1997 (1997-10-01), pages 289 - 296, XP004570106, ISSN: 0378-1119 *
See also references of WO0153312A1 *

Also Published As

Publication number Publication date
WO2001053312A8 (en) 2002-06-20
WO2001053312A1 (en) 2001-07-26
CA2402563A1 (en) 2001-07-26
EP1242443A1 (de) 2002-09-25

Similar Documents

Publication Publication Date Title
EP1242443A4 (de) Neue nukleinsäuren und polypeptide
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1325120A4 (de) Neue nukleinsäuren und polypeptide
EP1341804A4 (de) Neue nukleinsäuren und polypeptide
IL206414A0 (en) Novel receptor nucleic acids and polypeptides
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
EP1381621A4 (de) Neue nukleinsäuren und polypeptide
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
EP1276751A4 (de) Neue nukleinsäuren und polypeptide
EP1368475A4 (de) Neue nukleinsäuren und polypeptide
AU2001250872A1 (en) Novel nucleic acids and polypeptides
WO2002016439A8 (en) Novel nucleic acids and polypeptides
EP1341803A4 (de) Neue nukleinsäuren und polypeptide
EP1239039A4 (de) Neues polypeptid und dafür kodierende dna
AU3511100A (en) Novel nucleic acids and polypeptides
HUP0201660A2 (en) Novel polypeptide and dna thereof
AU2001263005A8 (en) Novel nucleic acids and polypeptides
EP1268762A4 (de) Neue nukleinsäuren und polypeptide
AU1453601A (en) Novel polypeptides and nucleic acids encoding same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020624

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 15/11 B

Ipc: 7C 07K 14/00 B

Ipc: 7C 12N 15/63 B

Ipc: 7C 07H 21/04 A

Ipc: 7C 07K 14/435 B

Ipc: 7C 12N 15/70 B

A4 Supplementary search report drawn up and despatched

Effective date: 20050509

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060111